These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 21556469)
41. [Resistance of Mycobacterium tuberculosis in Mexican patients. I. Clinical features and risk factors]. Sifuentes-Osornio J; Ponce-de-León LA; Camacho-Mezquita FE; Bobadilla-del-Valle JM; Infante-Suárez ML; Ramírez-Fernández N; Hernández-Gómez L; Nelson AM Rev Invest Clin; 1995; 47(4):273-81. PubMed ID: 8525129 [TBL] [Abstract][Full Text] [Related]
42. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital. Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385 [TBL] [Abstract][Full Text] [Related]
43. Drug resistant tuberculosis in Estonia. Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123 [TBL] [Abstract][Full Text] [Related]
44. Antituberculosis drug resistance in the south of Vietnam: prevalence and trends. Huong NT; Lan NT; Cobelens FG; Duong BD; Co NV; Bosman MC; Kim SJ; van Soolingen D; Borgdorff MW J Infect Dis; 2006 Nov; 194(9):1226-32. PubMed ID: 17041848 [TBL] [Abstract][Full Text] [Related]
45. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment. Kam KM; Yip CW Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892 [TBL] [Abstract][Full Text] [Related]
46. Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia. Shamputa IC; Jugheli L; Sadradze N; Willery E; Portaels F; Supply P; Rigouts L Respir Res; 2006 Jul; 7(1):99. PubMed ID: 16846493 [TBL] [Abstract][Full Text] [Related]
47. [Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs]. Sayğan MB; Ocak F; Cesur S; Tarhan G; Ceyhan I; Gümüişlü F; Beker G; Güner U; Coşkun E Mikrobiyol Bul; 2007 Jul; 41(3):403-9. PubMed ID: 17933251 [TBL] [Abstract][Full Text] [Related]
48. Drug resistance pattern of mycobacterium tuberculosis complex at a medical center in central Taiwan, 2003-2007. Yu CC; Chang CY; Liu CE; Shih LF; Hsiao JH; Chen CH J Microbiol Immunol Infect; 2010 Aug; 43(4):285-90. PubMed ID: 20688288 [TBL] [Abstract][Full Text] [Related]
53. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2002: a report of the Australian Mycobacterium Reference Laboratory Network. Lumb R; Bastian I; Chew W; Gilpin C; Haverkort F; James G; Sievers A Commun Dis Intell Q Rep; 2003; 27(4):459-65. PubMed ID: 15508499 [TBL] [Abstract][Full Text] [Related]
54. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria. Ani AE; Idoko J; Dalyop YB; Pitmang SL Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):67-71. PubMed ID: 18789463 [TBL] [Abstract][Full Text] [Related]
55. Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996. Riantawan P; Punnotok J; Chaisuksuwan R; Pransujarit V Int J Tuberc Lung Dis; 1998 Aug; 2(8):616-20. PubMed ID: 9712274 [TBL] [Abstract][Full Text] [Related]
56. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece. Trakada G; Tsiamita M; Spiropoulos K Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340 [TBL] [Abstract][Full Text] [Related]
57. First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey. Yazısız H; Hırçın Cenger D; Yazısız V; Kılıç L; Altın S Tuberk Toraks; 2019 Jun; 67(2):92-101. PubMed ID: 31414639 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001 [TBL] [Abstract][Full Text] [Related]
59. Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia. Demissie M; Gebeyehu M; Berhane Y Int J Tuberc Lung Dis; 1997 Feb; 1(1):64-7. PubMed ID: 9441061 [TBL] [Abstract][Full Text] [Related]
60. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China. Shi R; Zhang J; Otomo K; Zhang G; Sugawara I Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]